Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Crit Care Med. 2012 Jun;40(6):1731–1737. doi: 10.1097/CCM.0b013e3182451c87

Table 3.

Quartiles of baseline angiopoietin-2 and von Willebrand factor and ventilator-free days in patients with acute lung injury

Baseline Biomarker Level Mean Change in Ventilator-Free Days (95% Confidence Interval) p
Angiopoietin-2 (infection-related acute lung injury)
First quartile Referent N/A
Second quartile −2.2 (−4.6 to 0.16) .07
Third quartile −2.5 (−4.8 to −0.1) .04
Fourth quartile −4.1 (−6.3 to −1.8) <.001
Test for trend across quartiles .006

Angiopoietin-2 (noninfection-related acute lung injury)
First quartile Referent N/A
Second quartile −2.4 (−5.4 to 0.7) .13
Third quartile −7.1 (−10.3 to −3.9) <.001
Fourth quartile −5.7 (−9.6 to −1.8) .004
Test for trend across quartiles .0001

von Willebrand factor
First quartile Referent N/A
Second quartile −0.5 (−2.4 to 1.4) .59
Third quartile −1.9 (−3.8 to −0.03) .046
Fourth quartile −4.6 (−6.5 to −2.7) <.001
Test for trend across quartiles <.0001

N/A, not applicable.